SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015252
Filing Date
2023-04-27
Accepted
2023-04-27 16:03:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2023_defa14a_-_notice_ca.htm DEFA14A 37210
2 GRAPHIC img42944950_0.jpg GRAPHIC 505867
3 GRAPHIC img42944950_1.jpg GRAPHIC 359927
  Complete submission text file 0000950170-23-015252.txt   1230180
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38542 | Film No.: 23856687
SIC: 2834 Pharmaceutical Preparations